RESEARCH NOTE
·
Medadvisor Ltd (MDR)
Does this medication technology stock have the potential to deliver great returns to investors?
Healthcare
Daily
ASX
This report is available to subscribers
The full research note on Medadvisor Ltd — our view, the levels we are working to and the reasoning behind them — is part of a Kapitales subscription.